Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1343881

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to have discussions with representatives of Novavax on the release of antibody test results to unblinded participants in the Novavax covid-19 vaccine trial.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	27363
answer	answer is ministerial correction date of answer 19/07/2021 answer text <p>We have no current plans to do so. Individuals who participate in trials should speak to their trial contact on such matters as the release of test results. The Department will ensure that trial participants are not disadvantaged in terms of any future domestic vaccine certification, if introduced, compared to anyone else who has had their vaccines under the standard National Health Service programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 19/07/2021 15:23:59 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4811 label Biography information for Navendu Mishra

1343882

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what guidance his Department provides to Novavax covid-19 vaccine trial participants who have been unblinded and received two vaccine doses under that trial over six months ago on whether they should receive an approved covid-19 vaccination.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	27364
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>Guidance has been provided to support vaccine trial participants who wished to be unblinded at a time when they became eligible for an approved COVID-19 vaccine. This suggests individuals should discuss with the principle investigator at the site in which the participant was recruited who are best placed to advise on the options following unblinding.</p><p>In general, participants who only received a placebo would be recommended to receive the deployed COVID-19 vaccine schedule. Those that received a full course of an active vaccine, would be advised that further doses of deployed vaccine were not advisable. Whilst antibody tests were performed in the study, the advice on further vaccination would be based on the record of the participant's previous doses in the trial.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 27365 question first answered 13/07/2021 15:33:36 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4811 label Biography information for Navendu Mishra

1343883

registered interest
date	05/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what (a) advice and (b) support his Department is providing to Novavax covid-19 vaccine trial participants who have been unblinded but do not have access to their antibody test results and are unsure of their level of protection against the covid-19 virus.
tabling member constituency	Stockport
tabling member printed	Navendu Mishra
uin	27365
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>Guidance has been provided to support vaccine trial participants who wished to be unblinded at a time when they became eligible for an approved COVID-19 vaccine. This suggests individuals should discuss with the principle investigator at the site in which the participant was recruited who are best placed to advise on the options following unblinding.</p><p>In general, participants who only received a placebo would be recommended to receive the deployed COVID-19 vaccine schedule. Those that received a full course of an active vaccine, would be advised that further doses of deployed vaccine were not advisable. Whilst antibody tests were performed in the study, the advice on further vaccination would be based on the record of the participant's previous doses in the trial.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 27364 question first answered 13/07/2021 15:33:36 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4811 label Biography information for Navendu Mishra